Long-term effects of COVID-19 in diabetic and non-diabetic patients

Ricardo Wesley Alberca1, Yasmim Álefe Leuzzi Ramos1, Nátalli Zanete Pereira1

  • 1Laboratorio de Dermatologia e Imunodeficiencias (LIM-56), Departamento de Dermatologia, Faculdade de Medicina FMUSP, Institute de Medicina Tropical da Universidade de Sáo Paulo, Sáo Paulo, Brazil.

Frontiers in Public Health
|September 1, 2022
PubMed

Insights

COVID-19 infection may lead to long-term changes in blood sugar levels, even in non-diabetic individuals. This study tracked COVID-19 patients post-recovery, finding elevated blood glucose and HbA1c in those without prior diabetes diagnoses.

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • Immunology

Background:

  • Previous research indicates a link between diabetes, inflammation, and coagulation during COVID-19.
  • The long-term effects of COVID-19 on diabetic patients remain under-investigated.

Purpose of the Study:

  • To longitudinally analyze COVID-19-associated biomarkers in patients with and without diabetes.
  • To assess potential long-term complications following COVID-19 recovery.
  • To evaluate changes in glycemic control and inflammatory markers three and six months post-infection.

Main Methods:

  • Recruited 128 patients for a longitudinal study.
  • Monitored COVID-19-associated biomarkers at three and six months post-recovery.
  • Assessed glycemic control (glycemia, glycated hemoglobin) and beta-cell function (c-peptide test).

Main Results:

  • No significant long-term modifications in inflammatory biomarkers were observed.
  • Non-diabetic patients showed increased glycemia and glycated hemoglobin post-COVID-19.
  • Both diabetic and non-diabetic patients exhibited elevated glycated hemoglobin levels.
  • C-peptide tests confirmed normal beta-cell function across all participants.

Conclusions:

  • COVID-19 may induce transient or lasting alterations in glucose metabolism, particularly in non-diabetic individuals.
  • Elevated glycated hemoglobin post-COVID-19 warrants further investigation into potential long-term metabolic complications.
  • Beta-cell function appears preserved in most patients after COVID-19, irrespective of diabetes status.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
666
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.5K